Although more clinical samples and more in-depth experiments are needed to explore the mechanism of TRIB3 in the future, our results suggest that TRIB3 is a potential prognostic marker and therapeutic target in bladder cancer. This evidence concerns the gene TRIB3 and urinary bladder carcinoma.